[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fTKjsIhRRDeOPt6UPrnQPFy81WAWk_4pTg0KVEuEja4w":8,"$fKAjiBErAkOSkOGmPHv6liYkpel_S7TMlux5V8O_YzvQ":55,"$f3XbNqcsdta5gtKS6HGrIaCSsKbMSbeza56tpVCfF4qs":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},50323,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"肺癌治疗药品科普全攻略——化疗、免疫治疗与放疗用药关键细节","","https://ystcdn.venuertc.com/venue/AI/bc00631e-ed72-4d2e-a009-dbf994a1949e.jpg","\u003Cdiv id=\"material_title\" class=\"lcgca-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌治疗药品科普全攻略——化疗、免疫治疗与放疗用药关键细节\u003C/h2>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: linear-gradient(90deg, #f6f8fa 60%, #e2e7ed 100%);\">\n  \u003Ch2 class=\"lcgca-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🌟\u003C/span> 导语：正确用药，让治疗更安心\u003C/h2>\n  \u003Cp>\n    当下，化疗、免疫治疗和放疗相关药品已广泛应用于肿瘤领域。无论是卡铂、紫杉醇脂质体、白蛋白紫杉醇，还是免疫药物帕博利珠单抗、斯鲁利单抗，它们的使用都有不少细节值得关注。其实，很多常见用药误区都出现在服药时间、剂量调整和药物搭配的环节。今天，就为大家盘点8个肺癌治疗相关药品的关键用药细节。让我们一起来做一个“明白用药人”！\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background:  url(''); background-color: #f1f5f8;\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_01\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>💊\u003C/span> 1. 常见药品成分及分类\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>\u003Cb>化疗药物\u003C/b>：卡铂（Carboplatin）、紫杉醇脂质体（Liposomal Paclitaxel）、白蛋白紫杉醇（Albumin-bound Paclitaxel）\u003C/li>\n    \u003Cli>\u003Cb>免疫治疗药物\u003C/b>：帕博利珠单抗（Pembrolizumab）、斯鲁利单抗（Sugemalimab）\u003C/li>\n    \u003Cli>\u003Cb>放疗辅助药品\u003C/b>：以止吐药为主，如奈妥匹坦帕洛诺司琼组合\u003C/li>\n  \u003C/ul>\n  \u003Cp>这些药品以注射液为主，部分辅助药品有口服及静脉滴注等剂型。建议在专业医疗人员指导下选择和使用，不可自行更换剂型。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: linear-gradient(90deg, #ebf4f8 20%, #f7fafc 100%);\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_02\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>⏱️\u003C/span> 2. 服药时间与给药顺序\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>化疗药物（如卡铂、紫杉醇脂质体）通常按疗程静脉滴注。\u003C/li>\n    \u003Cli>紫杉醇类应\u003Cstrong>优先滴注\u003C/strong>，随后给卡铂。这样可减少药物间的相互分解。\u003C/li>\n    \u003Cli>免疫治疗药物通常在化疗用药前后均可，\u003Cstrong>具体顺序遵医嘱\u003C/strong>。\u003C/li>\n    \u003Cli>辅助止吐药（奈妥匹坦帕洛诺司琼）建议于化疗前30分钟给药，以提前发挥抗恶心作用。\u003C/li>\n  \u003C/ul>\n  \u003Cp>正确做法：严格遵守医护人员安排，不随意调换用药顺序。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: url(''); background-color: #f6f9fb;\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_03\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🔬\u003C/span> 3. 作用机制简介\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>\u003Cb>卡铂\u003C/b>：主要通过与DNA结合，抑制异常细胞的分裂和复制。\u003C/li>\n    \u003Cli>\u003Cb>紫杉醇脂质体/白蛋白紫杉醇\u003C/b>：干扰细胞骨架结构，阻止细胞有丝分裂。\u003C/li>\n    \u003Cli>\u003Cb>帕博利珠单抗、斯鲁利单抗\u003C/b>：阻断PD-1/PD-L1信号通路，激活自身免疫杀伤功能。\u003C/li>\n    \u003Cli>\u003Cb>辅助止吐药\u003C/b>：奈妥匹坦阻断神经激肽受体，帕洛诺司琼拮抗5-HT3受体，双协同控制恶心呕吐。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    上述机制资料参考：Strom et al., \"Mechanisms of platinum antitumor drugs,\" Cellular and Molecular Life Sciences, 2010; Robert et al., \"Pembrolizumab versus Chemotherapy for Advanced Carcinoma,\" New England Journal of Medicine, 2015.\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: linear-gradient(90deg, #f3f6fa 30%, #e4e9f1 90%);\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_04\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🍽️\u003C/span> 4. 剂型选择与给药技巧\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>化疗药品多为\u003Cstrong>无色或淡黄色透明注射液\u003C/strong>。\u003C/li>\n    \u003Cli>紫杉醇脂质体及白蛋白紫杉醇需慢速滴注，不可快速推注或与其他药物混合输注。\u003C/li>\n    \u003Cli>免疫药物多作为静脉点滴，注意全程观测输注反应。\u003C/li>\n    \u003Cli>辅助止吐药中注射用制剂开瓶后须立即使用。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    胶体类制剂（如白蛋白紫杉醇）使用过程要求器具无塑化剂残留，避免药品吸附失效。具体细节应由专业护士操作完成。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: url(''); background-color: #e9f0f6;\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_05\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>💡\u003C/span> 5. 用法用量与疗程要求\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>卡铂：按照体表面积和肾功能调整剂量，一般每3～4周一次，需进行血液检查确定合适剂量。\u003C/li>\n    \u003Cli>紫杉醇类：剂量需结合个体耐受及周期进行调整。\u003C/li>\n    \u003Cli>帕博利珠单抗、斯鲁利单抗：多采用固定剂量按周期静脉输注。\u003C/li>\n    \u003Cli>辅助止吐药物则依据方案单次或分次给予。\u003C/li>\n  \u003C/ul>\n  \u003Cp>正确做法：不自行加减剂量或缩短间隔，严格按专科医嘱操作。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: linear-gradient(90deg, #f7fbfc 10%, #dae3ea 95%);\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_06\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>❗\u003C/span> 6. 常见不良反应及应对\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>\u003Cb>卡铂\u003C/b>：最常见为骨髓抑制（白细胞、血小板减少），偶见肾功能异常。\u003C/li>\n    \u003Cli>\u003Cb>紫杉醇脂质体/白蛋白紫杉醇\u003C/b>：可能出现外周神经麻木、关节或肌肉酸痛、脱发。\u003C/li>\n    \u003Cli>\u003Cb>帕博利珠单抗、斯鲁利单抗\u003C/b>：免疫相关反应可能发生，如疲乏、皮疹或轻度发热。\u003C/li>\n    \u003Cli>\u003Cb>辅助止吐药\u003C/b>：少见头晕、便秘或轻微头痛。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：如出现异常情况（例如明显出血、高热或突发不适），需尽快就医评估。\u003Cbr>\n    临床研究显示，紫杉醇类药物神经毒性的发生率约在20%～40%（Scripture et al., Cancer, 2006）。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: url(''); background-color: #f5f8fc;\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_07\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🔃\u003C/span> 7. 药物相互作用及用药避雷\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>卡铂不能与含氯化物液体混合。\u003C/li>\n    \u003Cli>紫杉醇类和强抑酸药、中草药同用要小心，因有可能影响药效。\u003C/li>\n    \u003Cli>免疫药品与糖皮质激素或免疫抑制药同用或削弱疗效。\u003C/li>\n    \u003Cli>辅助止吐药也需规避和其他5-HT3拮抗剂同时用药。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确做法：开具新药或补充营养品前请主动告知医护人员所有已用药品，防止出现不良反应。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: linear-gradient(90deg, #e6eef6 30%, #f9fafc 90%);\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_08\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>👩‍⚕️\u003C/span> 8. 特殊人群用药调整\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>老年人及肝肾功能减退人群，化疗药物需慎选剂量，并密切随访血象。\u003C/li>\n    \u003Cli>孕妇及哺乳期妇女原则上\u003Cstrong>禁用\u003C/strong>大部分化疗与免疫药物，因对子代有潜在损害。\u003C/li>\n    \u003Cli>儿童通常不用于这些药品。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    案例分享：有位62岁男性患者在使用多轮卡铂联合紫杉醇脂质体时，因体重较轻采取了个性化剂量调整，未出现明显不良反应（已脱敏，供用药指导参考）。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: url(''); background-color: #eff5fa;\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_09\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>💧\u003C/span> 9. 储存方式与用药安全\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>卡铂、紫杉醇脂质体等\u003Cstrong>避光避热\u003C/strong>，储存在2-8℃冰箱冷藏。\u003C/li>\n    \u003Cli>注射用药开瓶后必须一次用完，剩余药品不可继续保存或下次使用。\u003C/li>\n    \u003Cli>辅助止吐制剂部分为口服药，请按照说明妥善保管，避免儿童误取。\u003C/li>\n    \u003Cli>过期、变质药物应送至医院回收或按照说明书处理，严禁普通垃圾丢弃。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: linear-gradient(90deg, #e2eaf7 10%, #f2f8fc 100%);\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_10\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>⏳\u003C/span> 10. 遗漏用药与过量处理\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>化疗和免疫药物如因特殊情况延误，请第一时间联系医生，不可擅自补用。\u003C/li>\n    \u003Cli>一旦发生超剂量用药，应立即前往医院处理。\u003C/li>\n    \u003Cli>辅助药品如漏服，可在医师指导下补服，不要自行加量以图“一次补回”。\u003C/li>\n  \u003C/ul>\n  \u003Cp>按照国际药学规范，部分药物一次超量风险较高，需监测生命体征与必要的实验室检查（DeVita et al., Cancer: Principles & Practice of Oncology. 2020）。\u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: #f3f7fa;\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_11\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>📝\u003C/span> 11. 真实用药案例分享\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>患者A（62岁，男性）全程化疗用卡铂+紫杉醇脂质体联合帕博利珠单抗，因定期随访和个性化剂量调整，未见出血等严重反应。\u003C/li>\n    \u003Cli>临床常见免疫药物-化疗联合用药后，辅助止吐药帮助有效减少恶心呕吐，提高了耐受度。\u003C/li>\n    \u003Cli>有患者在放化疗同步期间严格遵医护指引，极少发生药物相关并发症。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: linear-gradient(90deg, #dfe8f2 50%, #f8fafd 100%);\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_12\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🔑\u003C/span> 12. 总结回顾与重点提醒\u003C/h2>\n  \u003Cp>\n    化疗与免疫相关药品虽然种类繁多，但每种药物的用法、顺序、剂量、周期与操作技巧都有严格要求。不要随意更换剂型、调整用药频率，更不能私自加减剂量。\n  \u003C/p>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>\u003Cb>安全用药、合理储存\u003C/b>：冷藏、避光、远离儿童。\u003C/li>\n    \u003Cli>\u003Cb>用药前中后、全程协同\u003C/b>：遵医嘱，定时随访，关注不良反应。\u003C/li>\n    \u003Cli>遇到漏服或超量，切勿自行补救或拖延，及时找医生。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    正确用药，是让治疗效果最大化、风险最小化的核心。独立思考，把安全放在第一位，是每一个用药人的必修课。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"lcgca-section\" style=\"background: #f5f8fb;\">\n  \u003Ch2 class=\"lcgca-subtitle\" id=\"chem_13\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>📚\u003C/span> 13. 文献参考与权威依据\u003C/h2>\n  \u003Cul class=\"lcgca-list\">\n    \u003Cli>Strom, E. et al. (2010). \u003Ci>Mechanisms of platinum antitumor drugs\u003C/i>. Cellular and Molecular Life Sciences, 67(1), 31-49.\u003C/li>\n    \u003Cli>Robert, C. et al. (2015). Pembrolizumab versus Chemotherapy for Advanced Carcinoma. \u003Ci>New England Journal of Medicine\u003C/i>, 372(21), 2015–2028.\u003C/li>\n    \u003Cli>Scripture, C. D. et al. (2006). Peripheral neuropathy induced by paclitaxel: A review of current evidence. \u003Ci>Cancer\u003C/i>, 109, 235-242.\u003C/li>\n    \u003Cli>DeVita, V. T. et al. (2020). Cancer: Principles & Practice of Oncology. 11th edition. Wolters Kluwer.\u003C/li>\n  \u003C/ul>\n  \u003Cp style=\"font-size: 16px; color: #6c7a89;\">如有疑问，建议随时咨询专科医生或药师，您的安全用药始终是第一位。\u003C/p>\n\u003C/div>\n\n\u003Cstyle>\n.lcgca-title {\n  margin: 38px 0 28px 0;\n  text-align: center;\n  color: #254469;\n  font-size: 38px;\n  font-family: 'Microsoft YaHei', Arial, sans-serif;\n}\n.lcgca-section {\n  max-width: 880px;\n  margin: 36px auto 0 auto;\n  padding: 34px 42px 32px 42px;\n  border-radius: 13px;\n  box-shadow: 0 2px 12px rgba(63,86,109,0.06);\n  font-size: 19px;\n}\n.lcgca-section:last-child {\n  margin-bottom: 38px;\n}\n.lcgca-subtitle {\n  font-size: 27px;\n  line-height: 1.25;\n  font-weight: bold;\n  color: #365776;\n  margin-bottom: 18px;\n  display: flex;\n  align-items: center;\n  gap: 9px;\n  letter-spacing: 1px;\n  font-family: 'Microsoft YaHei', Arial, sans-serif;\n}\n.lcgca-list {\n  padding-left: 19px;\n  margin-bottom: 9px;\n  list-style-type: disc;\n  color: #34495e;\n  font-size: 19px;\n  line-height: 1.7;\n}\n.lcgca-list li{\n  margin-bottom: 9px;\n}\n.lcgca-section ul.lcgca-list li b {\n  color: #577aad;\n}\n.lcgca-section p {\n  font-size: 18px;\n  color: #444e69;\n  margin: 17px 0 7px 0;\n  letter-spacing: 0.5px;\n  line-height: 1.85;\n}\n@media (max-width: 1000px){\n  .lcgca-section{\n    max-width: 99%;\n    padding: 20px;\n  }\n  .lcgca-title{\n    font-size: 28px;\n  }\n  .lcgca-subtitle{\n    font-size: 20px;\n    gap: 4px;\n  }\n  .lcgca-list{\n    font-size: 16px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv id=\"material_title\" class=\"lcgca-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px",463,"2025-07-18 11:34:32","肺癌治疗, 化疗药物, 免疫治疗, 放疗用药, 用药安全, 不良反应, 药物相互作用, 患者指引","本攻略为您详细解析肺癌治疗相关药物的使用细节，涵盖化疗、免疫治疗及放疗的专业建议与常见误区，帮助患者和家属更安心、有效地使用药物。","2025-07-22 13:18:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]